Clinical trial
Bupropion as an Adjunct to the Nicotine Patch Plus CBT
NCT00142831 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00142831 |
|---|---|
| Title | Bupropion as an Adjunct to the Nicotine Patch Plus CBT |
| Official title | Effectiveness of Bupropion Used in Combination With the Nicotine Replacement Patch and Cognitive Behavioral Therapy for Treating Nicotine Dependent Individuals - 1 |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tobacco Use Disorder |
| Intervention type | Drug |
| Interventions | Pharmacotherapies for Smoking Cessation |
| Enrollment | 293 |
| Start date | Apr 1, 1999 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Sep 2, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: